[HTML][HTML] Integrated cognitive assessment: speed and accuracy of visual processing as a reliable proxy to cognitive performance

…, M Khanbagi, SM Nabavi, E Sadeghi, C Kalafatis - Scientific Reports, 2019 - nature.com
Various mental disorders are accompanied by some degree of cognitive impairment. Particularly
in neurodegenerative disorders, cognitive impairment is the phenotypical hallmark of …

[HTML][HTML] Implementing remote memory clinics to enhance clinical care during and after COVID-19

AP Owens, C Ballard, M Beigi, C Kalafatis… - Frontiers in …, 2020 - frontiersin.org
Social isolation is likely to be recommended for older adults due to COVID-19, with ongoing
reduced clinical contact suggested for this population. This has increased the need for …

Mild cognitive impairment: the Manchester consensus

…, RW Jones, S Mitchell, N Hooper, C Kalafatis… - Age and …, 2021 - academic.oup.com
Given considerable variation in diagnostic and therapeutic practice, there is a need for national
guidance on the use of neuroimaging, fluid biomarkers, cognitive testing, follow-up and …

[HTML][HTML] Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a …

…, H Rostamipour, P Gallagher, C Kalafatis… - The Lancet …, 2020 - thelancet.com
Background People living in group situations or with dementia are more vulnerable to infection
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Older people and …

Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents

D Bishara, C Kalafatis, D Taylor - Therapeutic advances in …, 2020 - journals.sagepub.com
As yet, no agents have been approved for the treatment of COVID-19, although several
experimental drugs are being used off licence. These may have serious adverse effects and …

[HTML][HTML] Validity and cultural generalisability of a 5-minute AI-based, computerised cognitive assessment in mild cognitive impairment and Alzheimer's dementia

C Kalafatis, MH Modarres, P Apostolou… - Frontiers in …, 2021 - frontiersin.org
Introduction: Early detection and monitoring of mild cognitive impairment (MCI) and Alzheimer's
Disease (AD) patients are key to tackling dementia and providing benefits to patients, …

[HTML][HTML] Wearable devices: underrepresentation in the ageing society

TW Guu, M Muurling, Z Khan, C Kalafatis… - The Lancet Digital …, 2023 - thelancet.com
In The Lancet Digital Health, Zinzuwadia and Singh commented on the bias and inequity in
studies that make use of wearable devices among the general population. 1 We appreciate …

[HTML][HTML] The use of the integrated cognitive assessment to improve the efficiency of primary care referrals to memory services in the accelerating dementia pathway …

MH Modarres, C Kalafatis, P Apostolou… - Frontiers in Aging …, 2023 - ncbi.nlm.nih.gov
Background Current primary care cognitive assessment tools are either crude or time-consuming
instruments that can only detect cognitive impairment when it is well established. This …

[HTML][HTML] A self-administered, artificial intelligence (AI) platform for cognitive assessment in multiple sclerosis (MS)

…, M Sadeghi, M Khanbagi, C Kalafatis… - BMC neurology, 2020 - Springer
Background Cognitive impairment is common in patients with multiple sclerosis (MS).
Accurate and repeatable measures of cognition have the potential to be used as markers of …

Early diagnosis of Alzheimer's dementia with the artificial intelligence‐based Integrated Cognitive Assessment: Neuropsychology/computerized neuropsychological …

…, R Ebrahimpour, Z Vahabi, C Kalafatis… - Alzheimer's & …, 2020 - Wiley Online Library
Background We have developed the Integrated Cognitive Assessment (ICA), a 5‐minute,
self‐administered, computerised test that is independent of language, cultural background and …